Searchable abstracts of presentations at key conferences in endocrinology

ea0026p488 | Thyroid cancer | ECE2011

Radiodine therapy and age at menopause in women with differentiated thyroid cancer

Martins T , Azevedo T , Martinho M , Oliveira S , Neto J , Rodrigues F

Introduction: Radiodine (131I) is widely used in the treatment of patients with thyroid cancer. This therapy is associated with some adverse effects including possible impairment of ovarian function and earlier menopause.Objective: The aim of this study was to evaluate female fertility after treatment with 131I of differentiated thyroid cancer (DTC).Methods: We retrospectively analysed 250 women with DTC treat...

ea0026p213 | Pituitary | ECE2011

Hypothalamic tumor in a patient with Pendred syndrome

Giestas A , Almeida M , Teixeira S , Maia A , Azevedo T , Vaz D , Carvalho A , Carvalho R

Introduction: Pendred syndrome is a rare autosomal recessive disease and the classic triad is congenital sensorineural hearing impairment, goiter and impaired iodine organification with abnormal perchlorate discharge test, but hypothalamic tumors are not a feature of this syndrome.Case report: We report a case of a 32-year-old female with Pendred syndrome confirmed by genetic testing and perchlorate discharge test, with goiter, hypothyroidism treated wit...

ea0026p594 | Clinical case reports | ECE2011

Acute respiratory distress syndrome in a nonsurgical transsexual

Giestas A , Almeida M , Teixeira S , Maia A , Azevedo T , Vaz D , Palma I , Carvalho R

Introduction: Liquid silicone is an inert material that as minimal local tissue reaction, but it is the systemic complications, such as silicone embolism and acute respiratory distress syndrome (ARDS) that carry the highest associated morbidity. Liquid silicone is frequently used for illegal cosmetic procedures in transsexual patients, and the most common injection sites are the hips, buttocks, face and breasts.We report a case of silicone embolism with ...

ea0026p484 | Thyroid cancer | ECE2011

Seventh UICC/TNM staging criteria for medullary thyroid carcinoma: is there any prognostic advantage?

Martinho M , Azevedo T , Carrilho F , Martins T , Ribeiro C , Melo M , Cunha N , Rascao M J , Neves A , Gilde P , Pires J L , Cruz C , Oliveira C , Neto J , Oliveira S , Valido F , Gomes I , Carvalheiro M , Rodrigues F

Background and aims: The value of the revised (2009) UICC/TNM criteria for medullary thyroid cancer (MTC) is not established. We aimed to evaluate its predictive value, analyzing the consequences of the inclusion of T3N0M0 patients previously included in stage III of the 6th edition, in stage II of the 7th.Patients and methods: We retrospectively analysed the clinical records of 85 patients operated for MTC and followed in two tertiary hospitals in the c...

ea0026p485 | Thyroid cancer | ECE2011

Very low-risk papillary thyroid carcinoma: where to set the limits?

Martinho M , Azevedo T , Martins T , Cunha N , Rascao M J , Oliveira C , Neto J , Oliveira S , Gilde P , Neves A , Gomes I , Cruz C , Valido F , Campos B , Rodrigues F

Currently there is no widely accepted definition of very low-risk papillary thyroid carcinoma (PTC). Although unifocal microcarcinomas without extrathyroidal extension and no local or distant metastases have been recognized as having an excellent overall prognosis the threshold for such a favourable clinical behaviour remains controversial. The study aim was to identify the clinicopathological characteristics of T1 tumours (≤2 cm) presenting a very low-risk of mortality ...